Utilization of nude mice in research on human cancer--screening system of anticancer agents using human tumor xenografts in nude mice
- PMID: 3601990
Utilization of nude mice in research on human cancer--screening system of anticancer agents using human tumor xenografts in nude mice
Abstract
Human cancers including eleven lines of stomach cancer, thirteen lines of lung cancer and six lines of glioma xenotransplated in nude mice were tested for experimental treatment by seven different anticancer agents in the present project. The doses used in this experiment were the maximum tolerated dose (MTD) and rational dose (RD) which was determined to maintain the blood level of drugs in nude mice the same as that in humans to obtain clinical effectiveness. In this experimental regimen, the response rate (number of effective lines/number of total lines tested) in the MTD treated group was much higher than the clinical response rate, but the response rate in the RD-administered group was almost the same as the clinical response rate.
Similar articles
-
[Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel].Gan To Kagaku Ryoho. 1991 Jul;18(9):1429-37. Gan To Kagaku Ryoho. 1991. PMID: 1854213 Japanese.
-
[Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].Gan To Kagaku Ryoho. 1991 Oct;18(13):2263-70. Gan To Kagaku Ryoho. 1991. PMID: 1929447 Japanese.
-
Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).In Vivo. 1987 Jan-Feb;1(1):1-13. In Vivo. 1987. PMID: 2979758 Review.
-
[Application of nude mouse-human cancer xenograft system for sensitivity test of anticancer drugs].Gan To Kagaku Ryoho. 1982 Apr;9(4):606-15. Gan To Kagaku Ryoho. 1982. PMID: 7184418 Japanese.
-
Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.Eur J Cancer. 2004 Apr;40(6):827-36. doi: 10.1016/j.ejca.2003.11.028. Eur J Cancer. 2004. PMID: 15120038 Review.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous